"Island Retina is a unique retinal practice. Dr. Pamela Weber will provide you with the most state-of-the-art retinal treatment in a private, comfortable setting. We have two locations in Suffolk County. Both offices provide laser treatment, minor surgical procedures and advanced diagnostic equipment. In addition, the William Floyd Center has a Medicare approved ambulatory surgery center. Dr Weber's staff is trained to facilitate your visit, and provide advanced diagnostic testing in a friendly, warm environment. We take pride in providing shorter wait times. Multiple research projects are conducted in our practice to provide patients with cutting edge technology. If you suffer from retinal disease, please call us. We accept most insurances."

During the past decade, Island Retina conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Island Retina" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Aerpio Therapeutics" with 1 trials sponsored, "Alimera Sciences" with 1 trials sponsored, "Allegro Ophthalmics, LLC" with 1 trials sponsored and "Allergan" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Island Retina" #1 collaborator was "Duke University" with 1 trials as a collaborator and "Trial Runners, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Island Retina" are "Diabetic Macular Edema" (3 trials), "Diabetic Macular Edema (DME)" (1 trials), "Exudative Age-related Macular Degeneration" (1 trials), "Macular Degeneration" (1 trials) and "Macular Edema" (1 trials). Many other conditions were trialed in "Island Retina" in a lesser frequency.

Most popular intervention types in "Island Retina" are "Drug" (10 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (5 trials), "Faricimab" (4 trials), "Aflibercept" (2 trials), "0.5 mg Lucentis or 1.25 mg Avastin or 2 mg Eylea" (1 trials) and "0.5 mg iSONEP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Island Retina" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Island Retina". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Island Retina, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Island Retina, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".